SANTA CLARA, Calif., Nov. 16, 2017 /PRNewswire/ -- Frost & Sullivan, the growth partnership company, announced today
2018 will bridge the gap between artificial intelligence (AI) and humans with Man-machine collaboration, leaving aside the man versus machine competition. Non-traditional players such as Amazon, Apple, Google, and IBM will begin to have a tangible implication in the healthcare ecosystem. Competing outside their conventional arena, these organizations are pushing traditional healthcare companies to break their main business model and make healthcare more accessible, affordable, and consumer-centric.
"Algorithms have outperformed humans in many cases. In 2018 the work of AI will begin to see fruition particularly in the diagnostic imaging market. Therefore, clinicians will start embracing this technology and use it more freely and easily," explained Reenita Das.
Next year will be a tipping point for mainstream adoption of popular digital health technology solutions such as artificial intelligence (AI), internet of medical things (IoMT), Big Data analytics, and robotics across select healthcare use cases. In addition, Cloud based PaaS/SaaS platforms will be integral to any healthcare data monetization model. The transition of these technologies from ideation to actionable applications will drive growth opportunities across the globe.
"Blockchain technology will move from perceived hype to reality bandwagon demonstrating real value with initial commercial deployments across health insurance claim adjudication and revenue cycle management use cases. The debate will now move onto the topic of adoption, exploring [how] and [where] can blockchain technology be used in the healthcare space," noted Kamaljit Behera.
The informative webinar will cover key insights:
For more information and to register for the webinar, click here. The event will also be recorded and available for on-demand viewing at http://frost.ly/1ti.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
For more information, visit ww2.frost.com or call +1 (877) 463-7678.
Frost & Sullivan
+1 (210) 348.1012
View original content:http://www.prnewswire.com/news-releases/2018-healthcare-predictions-how-will-man-machine-collaboration-redefine-the-global-market-300557814.html
SOURCE Frost & Sullivan
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All